Vanguard Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
OAM
Vanguard Capital Management's CDNA Position: Q2 2026 in Review
Vanguard Capital Management increased its CareDx (CDNA) stake by 1.7% in Q2 2026, buying an estimated $806K and bringing the position to 2,197,475 shares worth $62.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1810.
Vanguard Capital Management first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Vanguard Capital Management held 2,197,475 shares of CareDx worth $62.6M as of Q2 2026.
- Vanguard Capital Management bought 37,018 CareDx shares in Q2 2026, an estimated $806K.
- CareDx made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1810 holding.
- Vanguard Capital Management first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
- 225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.